Stocks and Investing
Stocks and Investing
Fri, May 10, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (ATXS) at Strong Buy and Held Target at $16 on, May 10th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "Astria Therapeutics, Inc." (ATXS) at Strong Buy and Held Target at $16 on, May 10th, 2024.
Joseph has made no other calls on ATXS in the last 4 months.
There are 2 other peers that have a rating on ATXS. Out of the 2 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Tuesday, March 26th, 2024
- Eun Yang of "Jefferies" Maintained at Strong Buy with Increased Target to $27 on, Monday, March 25th, 2024
Contributing Sources